Vigilare International Announces New Leadership

George S. Brenner, MBA, CPA joins Vigilare International as Vice President, Finance and Administration.

RADNOR, PA –5 October 2015 – Vigilare International today announced that George S. Brenner, MBA, CPA has joined Vigilare International as Vice President, Finance and Administration.

Mr. Brenner is a financial professional with over thirty years of experience in finance, accounting, drug, device and diagnostic development process management; budget and forecasting, financial statement preparation, financial analysis, cash management, mergers and acquisitions, financial restructuring, administration, and project management responsibilities. He is a results-driven, decisive leader with proven success in strategic thinking and problem solving and a track record of realizing double digit revenue growth and operating margin for 10+ years.

Mr. Brenner is a respected financial veteran with top-tier experience in contract research organizations (CROs). His responsibilities for Vigilare International include finance, accounting, legal, and business administration. Prior to joining Vigilare, George held positions as Senior Vice President Global Business Services at Numoda Corporation, Vice President, at United BioSource Corporation (UBC), Chief Financial Officer at RadPharm, Inc., Vice President, Finance and Administration at Covance – Periapproval Division, and Vice President of Finance for the Philadelphia Association for Clinical Trials (PACT), Director Corporate Audit and Control, Presbyterian University of Pennsylvania Medical Center, and Audit Supervisor with Deloitte and Touche.

Mr. Brenner earned his B.S. degree in accounting as well as his MBA from LaSalle University.

James A. Bannon, PharmD, CEO said: “George is a talented leader, who is well-respected by clients and employees alike” said Dr. Bannon. “He assisted in building Covance’s Periapproval division into a powerhouse and his deep knowledge of the industry and his ability to forge strong partnerships with new and existing clients will enable him to establish Vigilare as a leader in pharmacovigilance services.”

Mr. Brenner added “I look forward to once again joining Dr. Bannon and Kevin Flanagan, as well as Angela Pitwood and a Corporate Team that has a long and successful history of providing high quality services to the pharmaceutical industry.”

About Vigilare International (Vigilare)

Vigilare International provides its biopharmaceutical/biotech clients with focused pharmacovigilance services in support of marketed products, drug safety services in support of products in development and related services such as inspection readiness, gap analysis, and consulting and change management.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC